Pulmonx Cash on Hand 2019-2024 | LUNG

Pulmonx cash on hand from 2019 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Pulmonx Annual Cash on Hand
(Millions of US $)
2024 $102
2023 $117
2022 $141
2021 $180
2020 $232
2019 $28
2018 $4
Pulmonx Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $102
2024-09-30 $108
2024-06-30 $115
2024-03-31 $116
2023-12-31 $117
2023-09-30 $117
2023-06-30 $136
2023-03-31 $153
2022-12-31 $141
2022-09-30 $157
2022-06-30 $162
2022-03-31 $170
2021-12-31 $180
2021-09-30 $200
2021-06-30 $210
2021-03-31 $219
2020-12-31 $232
2020-09-30 $40
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2018-12-31 $4
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.152B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.476B 53.14
Tempus AI (TEM) United States $9.826B 0.00
Hims & Hers Health (HIMS) United States $9.069B 145.79
Inspire Medical Systems (INSP) United States $4.756B 92.38
IRhythm Technologies (IRTC) United States $4.186B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $2.016B 12.47
Schrodinger (SDGR) United States $1.847B 0.00
Clover Health Investments (CLOV) United States $1.706B 0.00
Phreesia (PHR) United States $1.512B 0.00
Omnicell (OMCL) United States $1.460B 31.48
Azenta (AZTA) United States $1.232B 57.36
10x Genomics (TXG) United States $1.031B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.537B 319.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.456B 0.00
TruBridge (TBRG) United States $0.392B 0.00
Claritev (CTEV) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.294B 0.00
Nyxoah SA (NYXH) Belgium $0.208B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
American Well (AMWL) United States $0.116B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.43
111 (YI) China $0.072B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Precipio (PRPO) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00